title: Further experience with the antireflux valve to prevent ascending cholangitis in biliary atresia.
abstract: OBJECTIVE
  The intussusception-type antireflux valve is a mechanism introduced by Nakajo, who reported the results of his initial 17 cases in 1990. This report summarizes our further experience with new patients, together with follow-up results of the cases previously reported by Nakajo.
  
  
  METHODS
  In total, 46 new patients who had biliary atresia underwent portoenterostomy at the authors' two units. The authors hoped to construct the intussuscepted antireflux valve in the Roux-en-Y loop, whenever possible, at the time of hepatic portoenterostomy.
  
  
  RESULTS
  Among the 46 patients, one case each was found to be too young or too old to have the valve constructed during the surgery. In another case, the Roux-en-Y loop became too short after repeated revisions of the portoenterostomy. In another patient, the valve was first constructed but later removed because of jejunal perforation near the valve. In the last patient, the valve was not constructed for unspecified reasons. The authors constructed the antireflux valve in 42 patients, but it was maintained in 41. In one case, the valve truly prevented reflux of the intestinal juice during an episode of intestinal obstruction. The valve was found to be incompetent in one patient 5 years after the initial surgery.
  
  
  CONCLUSIONS
  The incidence of cholangitis was high in patients with postoperative cystic dilatation of the intrahepatic bile ducts, and low in those without it.
authors.affiliation: Department of Pediatric Surgery, University of Tokyo, National Children's Hospital, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Honna
authors.forename: Y
authors.initials: Y
authors.lastname: Tsuchida
authors.forename: H
authors.initials: H
authors.lastname: Kawarasaki
authors.forename: T
authors.initials: T
authors.lastname: Utsuki
authors.forename: K
authors.initials: K
authors.lastname: Mizuta
mesh_terms: D001656:Biliary Atresia / Q000150:complications*; D002761:Cholangitis / Q000150:complications* / Q000517:prevention & control*; D005500:Follow-Up Studies; D005764:Gastroesophageal Reflux / Q000517:prevention & control* / Q000601:surgery*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011171:Portoenterostomy, Hepatic / Q000379:methods; D019919:Prosthesis Implantation; D012189:Retrospective Studies